Evidence map›Paper›PMID 42052249›Full record

ArticleSAGE open medicine2026

Positivity rate of QuantiFERON-TB Gold Plus

Hanane Mezenner, Hiba Ait Hamoudi, Soumia Naamoune, Meriem Abbadi, Meriem Khedimallah, Kafia Belhocine, Samira Zobiri, Yanis Meddour, Samia Taright, Sofiane Samir Salah

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in SAGE open medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hanane MezennerImmunology Department, Mustapha Bacha Teaching Hospital, Algiers, Algeria.ORCID https://orcid.org/0009-0008-5203-6618
Hiba Ait HamoudiImmunology Department, Mustapha Bacha Teaching Hospital, Algiers, Algeria.
Soumia NaamouneImmunology Department, Mustapha Bacha Teaching Hospital, Algiers, Algeria.
Meriem AbbadiImmunology Department, Mustapha Bacha Teaching Hospital, Algiers, Algeria.
Meriem KhedimallahImmunology Department, Mustapha Bacha Teaching Hospital, Algiers, Algeria.
Kafia BelhocineUniversity of Health Sciences, Algiers, Algeria.
Samira ZobiriUniversity of Health Sciences, Algiers, Algeria.
Yanis MeddourUniversity of Health Sciences, Algiers, Algeria.
Samia TarightUniversity of Health Sciences, Algiers, Algeria.
Sofiane Samir SalahImmunology Department, Mustapha Bacha Teaching Hospital, Algiers, Algeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Latent tuberculosis infection, an infection caused by Objectives: This study aimed to assess the place of QTF-Plus test in latent tuberculosis infection screening among a high-risk population. Methods: A total of 969 biotherapy candidates were included in the study (52.63% female and 47.36% male; sex ratio = 0.9). Results: The mean age was 38.29 ± 15.83 years. The frequency of latent tuberculosis infection, according to QTF-Plus test results, was 20.22%. Factors such as age and history of tuberculosis were significantly associated with QTF-Plus test results ( Conclusion: Our findings demonstrate that the QTF-Plus test is useful for latent tuberculosis infection screening in a highly vaccinated population with an intermediate prevalence of tuberculosis.

Indexed as

AlgeriaIGRALatent tuberculosis infectionQuantiFERON-TB Gold Plus®

Identifiers

PMID42052249
PMCPMC13111848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.